Menu Search
Equities

AJJ Medtech Holdings Ltd

584:SES

AJJ Medtech Holdings Ltd

Actions
Consumer DiscretionaryConsumer Services
  • Price (SGD)0.004
  • Today's Change0.00 / 0.00%
  • Shares traded5.00k
  • 1 Year change-42.86%
  • Beta0.3609
Data delayed at least 10 minutes, as of Nov 13 2024 00:58 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SGDIncome statement in SGDView more

Year on year AJJ Medtech Holdings Ltd grew revenues 170.97% from 596.00k to 1.62m while net income improved from a loss of 4.24m to a smaller loss of 2.53m.
Gross margin33.58%
Net profit margin-104.76%
Operating margin-102.77%
Return on assets-60.84%
Return on equity-1,119.13%
Return on investment-181.33%
More ▼

Cash flow in SGDView more

In 2023, AJJ Medtech Holdings Ltd increased its cash reserves by 140.59%, or 239.00k. Cash Flow from Financing totalled 1.66m or 102.48% of revenues. In addition the company used 1.79m for operations while cash from investing totalled 371.00k.
Cash flow per share-0.002
Price/Cash flow per share--
Book value per share0.0003
Tangible book value per share0.0002
More ▼

Balance sheet in SGDView more

AJJ Medtech Holdings Ltd has a Debt to Total Capital ratio of 77.96%, a lower figure than the previous year's 1,140.24%.
Current ratio1.04
Quick ratio0.5438
Total debt/total equity4.63
Total debt/total capital0.7796
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.